Adjuvant Therapy in Stage I Carcinoma of the Breast: The Influence of Multigene Analyses and Molecular Phenotyping

Breast Health International and the Kimmel Cancer Center of Thomas Jefferson University cosponsored a consensus conference that included an international group of experts. Since the adoption of adjuvant chemotherapy for stage I, lymph node-negative breast cancers in 1988, investigators have tried to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2012-04, Vol.118 (8), p.2031-2038
Hauptverfasser:	SCHWARTZ, Gordon F, REIS-FIHLO, Jorge, PUSZTAI, Lajos, FENTIMAN, Ian S, HOLLAND, Roland, BARTELINK, Harry, RUTGERS, Emiel J. T, SOLIN, Lawrence J, PALAZZO, Juan
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Breast Neoplasms - drug therapy Breast Neoplasms - genetics Breast Neoplasms - pathology Chemotherapy, Adjuvant Combined Modality Therapy Female Gene Expression Profiling Gynecology. Andrology. Obstetrics Humans Mammary gland diseases Medical sciences Neoplasms, Hormone-Dependent - drug therapy Neoplasms, Hormone-Dependent - metabolism Practice Guidelines as Topic Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!